NCT03271918View on ClinicalTrials.gov

Cabergoline in Nonfunctioning Pituitary Adenomas

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 1, 2015

Primary Completion Date

February 1, 2017

Study Completion Date

August 1, 2017

Conditions
Pituitary AdenomaNonfunctioning Pituitary Adenoma
Interventions
DRUG

Cabergoline

Trial Locations (1)

01402003

Laboratorio de Investigacoes Medicas 25, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT03271918 - Cabergoline in Nonfunctioning Pituitary Adenomas | Biotech Hunter | Biotech Hunter